Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$308K Buy
5,843
+187
+3% +$10.7K ﹤0.01% 2120
2026
Q1
$336K Buy
+5,656
New +$273K ﹤0.01% 1921

Other funds holding OVV

&Partners's OVV Position: Q2 2026 in Review

&Partners increased its Ovintiv (OVV) stake by 3.3% in Q2 2026, buying an estimated $10.7K and bringing the position to 5,843 shares worth $308K. The position accounts for ﹤0.01% of the portfolio, ranked #2120.

&Partners first reported a position in OVV in Q1 2026 and has held it in 2 quarters since. The position peaked at $336K in Q1 2026. 595 funds tracked by Wall St. Rank hold OVV as of Q2 2026.

  • &Partners held 5,843 shares of Ovintiv worth $308K as of Q2 2026.
  • &Partners bought 187 Ovintiv shares in Q2 2026, an estimated $10.7K.
  • Ovintiv made up ﹤0.01% of &Partners's portfolio in Q2 2026, its #2120 holding.
  • &Partners first reported a position in Ovintiv in Q1 2026 and has held it in 2 quarters since.
  • &Partners's Ovintiv position peaked at $336K in Q1 2026.
  • 595 funds tracked by Wall St. Rank held Ovintiv as of Q2 2026.

Based on &Partners's 13F filing for Q2 2026, filed 14 Aug 2026.